We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
(+6.3%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.46M |
| 2 |
HA
Hawaiian Holdings, Inc.
HA
|
+$8.23M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$7.93M |
| 4 |
CHSP
Chesapeake Lodging Trust
CHSP
|
+$7.89M |
| 5 |
Coca-Cola Consolidated
COKE
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KCG
KCG Holdings, Inc.
KCG
|
+$9.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.69M |
| 3 |
ePlus
PLUS
|
+$8.06M |
| 4 |
Murphy USA
MUSA
|
+$7.57M |
| 5 |
Thor Industries
THO
|
+$7.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Industrials | 15.81% |
| 3 | Technology | 13.65% |
| 4 | Consumer Discretionary | 11.93% |
| 5 | Healthcare | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
AMC Global Media
AMCX
$430M
| $687K | 0.06% |
+12,862
| New | +$719K |
|
202
Central Garden & Pet Co Class A
CENTA
$2.41B
| $677K | 0.06% |
28,183
-241,293
| -90% | -$6.17M |
|
|
AMAG
203
DELISTED
AMAG Pharmaceuticals
AMAG
| $671K | 0.06% |
36,447
+2,034
| +6% | +$40.3K |
|
|
BPFH
204
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $632K | 0.06% |
41,164
+16,506
| +67% | +$256K |
|
|
EXAC
205
DELISTED
Exactech Inc
EXAC
| $629K | 0.06% |
21,118
-1,117
| -5% | -$32.8K |
|
|
MGLN
206
DELISTED
Magellan Health Services, Inc.
MGLN
| $621K | 0.06% |
8,524
-123,693
| -94% | -$8.69M |
|
207
Vanda Pharmaceuticals
VNDA
$312M
| $621K | 0.06% |
38,075
-25,002
| -40% | -$360K |
|
208
Synaptics
SYNA
$4.41B
| $613K | 0.06% |
+11,854
| New | +$647K |
|
|
XENT
209
DELISTED
Intersect ENT, Inc
XENT
| $585K | 0.05% |
20,936
| – | – |
|
210
UNIFI
UFI
$117M
| $585K | 0.05% |
18,984
-43,525
| -70% | -$1.23M |
|
|
CMD
211
DELISTED
Cantel Medical Corporation
CMD
| $577K | 0.05% |
7,408
+2,763
| +59% | +$208K |
|
|
COBZ
212
DELISTED
CoBiz Financial,Inc
COBZ
| $571K | 0.05% |
32,808
+8,998
| +38% | +$148K |
|
213
OFG Bancorp
OFG
$2.21B
| $552K | 0.05% |
55,186
-8,133
| -13% | -$85.4K |
|
214
Materion
MTRN
$5.01B
| $551K | 0.05% |
+14,745
| New | +$521K |
|
215
Waterstone Financial
WSBF
$362M
| $537K | 0.05% |
28,478
-3,059
| -10% | -$57.6K |
|
216
Lear
LEA
$7.19B
| $535K | 0.05% |
3,766
| – | – |
|
217
PC Connection
CNXN
$2.05B
| $527K | 0.05% |
19,475
+912
| +5% | +$25.1K |
|
218
American Public Education
APEI
$875M
| $519K | 0.05% |
21,957
+481
| +2% | +$11K |
|
219
Costco
COST
$415B
| $512K | 0.05% |
+3,202
| New | +$552K |
|
|
EQC
220
DELISTED
Equity Commonwealth
EQC
| $508K | 0.05% |
16,068
-10,790
| -40% | -$341K |
|
221
ANI Pharmaceuticals
ANIP
$1.77B
| $502K | 0.05% |
10,733
-1,350
| -11% | -$65.1K |
|
222
Daktronics
DAKT
$941M
| $502K | 0.05% |
52,106
-5,693
| -10% | -$53.7K |
|
223
Travere Therapeutics
TVTX
$5.33B
| $492K | 0.05% |
25,355
+2,333
| +10% | +$42.3K |
|
224
Huntsman Corp
HUN
$2.24B
| $490K | 0.05% |
18,975
| – | – |
|
225
Cogent Communications
CCOI
$594M
| $488K | 0.05% |
+12,170
| New | +$504K |
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.
- Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
- Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
- Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
- Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
- Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
- Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.
Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.